New patent for Neurocrine drug ONGENTYS

Annual Drug Patent Expirations for ONGENTYS

Ongentys is a drug marketed by Neurocrine and is included in a single NDA. It’s out there from two suppliers. There are 9 patents defending this drug.

ONGENTYS drug worth tendencies.

This drug has 100 and 13 patent relations in thirty-one international locations.

The generic ingredient in ONGENTYS is opicapone. Two suppliers are listed for this compound. Extra particulars can be found on the opicapone profile web page.

For extra data on how DrugPatentWatch will help along with your pharmaceutical enterprise intelligence wants, contact admin@DrugPatentWatch.com or go to www.DrugPatentWatch.com